Results 51 to 60 of about 4,758 (125)

CD21: Probable ‘baboon syndrome’ triggered by hormone replacement therapy [PDF]

, 2021

openalex   +1 more source

The Role of Mesenchymal Stromal Cells in the Treatment of Bronchopulmonary Dysplasia: A Multi‐Prong Approach for a Heterogeneous Disease

Comprehensive Physiology, Volume 15, Issue 4, August 2025.
ABSTRACT Acute lung injury can be a devastating ailment leading to death in patients of all ages. In preterm neonates, lung injury is unique and unlike what is seen in pediatric and adult populations. The physiology behind the acute lung injury endured in developing lungs and the chronicity of harmful stimuli vastly distinguish how bronchopulmonary ...
Marc‐Olivier Deguise, Bernard Thébaud
wiley   +1 more source

The human photosensitive epilepsy model for clinical proof‐of‐principle trials of novel antiseizure medications: 2. Analysis of drug trials and predictive value of the model

Epilepsia, Volume 66, Issue 8, Page 2619-2638, August 2025.
Abstract Clinical development of novel antiseizure medications (ASMs) would benefit from an early proof of principle (POP) model. The photosensitivity model, which uses the photoparoxysmal electroencephalographic response (PPR) as a surrogate of seizures, is currently the only human model that allows POP trials of investigational compounds after a ...
Wolfgang Löscher, Dorothée Kasteleijn‐Nolst Trenité   +1 more
wiley   +1 more source

The human photosensitive epilepsy model for clinical proof‐of‐principle trials of novel antiseizure medications. 1. Use of the EEG in drug development and characteristics of the model

Epilepsia, Volume 66, Issue 8, Page 2605-2618, August 2025.
Abstract Clinical development of novel antiseizure medications (ASMs) would benefit from an early proof‐of‐principle (POP) model. The photosensitivity model, which uses the photoparoxysmal electroencephalography (EEG) response (PPR) as a surrogate for seizures, is currently the only human model that allows POP trials of investigational compounds after ...
Dorothée Kasteleijn‐Nolst Trenité, Wolfgang Löscher   +1 more
wiley   +1 more source

Intertriginous drug eruptions

Indian Journal of Dermatology, 2005
Drug eruptions confined to intertriginous areas are rare and unusual cutaneus manifestations of amoxicillin sensitivity. We describe here three such cases of intertriginous drug eruptions.
Mahajan Vikram, Sharma Ramesh
doaj  

The baboon syndrome after cinchocaine ointment [PDF]

, 2020
Ilário Froehner
openalex   +1 more source

Zoledronic acid-associated symmetrical drug-related intertriginous and flexural exanthema (SDRIFE): report of baboon syndrome in a woman with recurrent metastatic breast cancer after receiving zoledronic acid [PDF]

, 2015
Philip R. Cohen
openalex   +1 more source

Symmetrical drug-related intertriginous and flexural exanthema secondary to epidermal growth factor receptor inhibitor gefitinib

JAAD Case Reports, 2020
Beatrice Copps, BSc, Jean-Philip Lacroix, MD, Denis Sasseville, MD   +2 more
doaj   +1 more source

Baboon syndrome [PDF]

, 2009
M. N. Pemberton
openalex   +1 more source

Baboon syndrome caused by anti‐haemorrhoidal ointment [PDF]

, 2018
Eugénia Matos‐Pires, David Pina‐Trincão, Susana Brás, Lurdes Lobo   +3 more
openalex   +1 more source